GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Dr Agarwals Eye Hospital Ltd-$
Dr Agarwals Eye Hospital: Q1 FY27 Net Profit Rises to INR 23.38 Crores
RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 03 Aug 2026, 05:24 PM IST  ·  BSE ID: 29767418-a23e-4aa1-bcfc-a206c4c4883c
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's profit for the quarter rose to INR 23.38 Crores, and cost auditors were re-appointed.
🤖 AI Summary
  • Dr. Agarwals Eye Hospital reported a Net Profit After Tax of INR 23.38 Crores for the quarter ended June 30, 2026.
  • Revenue from operations for the quarter ended June 30, 2026, stood at INR 142.97 Crores.
  • The Board approved the unaudited financial results for the first quarter of financial year 2026-27.
  • M/s. B Y & Associates were re-appointed as the Cost Auditors for the Company for the financial year 2026-27.
  • The scheme of amalgamation with Dr. Agarwal's Health Care Limited has progressed, awaiting final NCLT sanction.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Net profit after tax for the period
INR 23.38 Crores
35.46%
Revenue from operations
INR 142.97 Crores
22.28%
Total income
INR 144.93 Crores
23.12%
Profit before tax
INR 30.96 Crores
33.51%
Earnings per equity share (Basic)
INR 48.38
31.74%
🏢 How This Affects the Company
📈
Business Impact
The increase in revenue from operations to INR 142.97 Crores indicates continued business activity in eye care related sales and services.
💰
Financial Impact
Net profit after tax increased to INR 23.38 Crores. The company has temporarily invested the unutilised portion of INR 70 crores preferential allotment proceeds in debt mutual funds.
⚙️
Operational Impact
Re-appointment of cost auditors ensures continuity in auditing cost records, maintaining regulatory compliance for financial year 2026-27.
⚠️
Risk Impact
The ongoing scheme of amalgamation with Dr. Agarwal's Health Care Limited, subject to NCLT sanction, introduces an element of regulatory risk until final approval.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance. Equity shareholders' earnings per share (basic and diluted) for Q1 FY27 stood at INR 48.38.
🔍
Management Signal
Management is focused on driving revenue and profit growth, ensuring compliance with audit requirements, and progressing with the approved amalgamation scheme.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Final sanction order for amalgamation scheme from Hon'ble NCLT
Q2 FY27 financial results to assess revenue and profit trends
Details on the utilization of remaining preferential allotment proceeds
LOW RISK The filing indicates positive financial results and ongoing corporate actions, with no new significant immediate risks.
💡 Investor Takeaway
Dr. Agarwals Eye Hospital reported Net Profit After Tax of INR 23.38 Crores for Q1 FY27, a 35.46% increase from INR 17.26 Crores in Q1 FY26. Revenue from operations reached INR 142.97 Crores, up from INR 116.92 Crores.
⚖️ Strengths & Concerns

✅ Positives

  • Net profit after tax increased to INR 23.38 Crores for the quarter ended June 30, 2026, compared to INR 17.26 Crores in the prior year comparable quarter.
  • Revenue from operations grew to INR 142.97 Crores for Q1 FY27, up from INR 116.92 Crores in Q1 FY26.

⚠️ Concerns

  • Finance costs increased to INR 2.77 Crores for Q1 FY27, compared to INR 1.96 Crores in the immediate prior quarter (Q4 FY26).
  • Total other comprehensive income/(loss) (net of tax) was a loss of INR (0.47) Crores in Q1 FY27, versus a gain of INR 0.04 Crores in Q1 FY26.
📅 Company Track Record
Dr. Agarwals Eye Hospital's Q1 FY27 Net Profit of INR 23.38 Crores represents a 35.46% increase compared to INR 17.26 Crores in Q1 FY26. The company recently saw its IPO in March 2026, indicating a limited public track record. Preferential issue of 1,32,827 equity shares worth INR 70 crores was approved in August 2025 and allotted in September 2025, with INR 28.20 crores utilized by June 30, 2026.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Dr. Agarwals Eye Hospital's net profit in Q1 FY27?
Dr. Agarwals Eye Hospital reported a Net Profit After Tax of INR 23.38 Crores for the quarter ended June 30, 2026.
What was Dr. Agarwals Eye Hospital's revenue from operations for Q1 FY27?
Revenue from operations for the quarter ended June 30, 2026, was INR 142.97 Crores.
Who was re-appointed as the Cost Auditors for Dr. Agarwals Eye Hospital?
M/s. B Y & Associates, Practicing Cost Accountants, were re-appointed as the Cost Auditors for the financial year 2026-27.
What is the status of the amalgamation scheme for Dr. Agarwals Eye Hospital?
The scheme of amalgamation with Dr. Agarwal's Health Care Limited received approval from equity shareholders and creditors on July 02, 2026, and remains subject to final sanction from the Hon'ble NCLT.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.